HomeCompareMNMD vs SPHD

MNMD vs SPHD: Dividend Comparison 2026

MNMD yields 10.58% · SPHD yields 4.33%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MNMD wins by $13.7K in total portfolio value
10 years
MNMD
MNMD
● Live price
10.58%
Share price
$18.91
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.2K
Annual income
$2,053.05
Full MNMD calculator →
SPHD
SPHD
● Live price
4.33%
Share price
$49.34
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$571.32
Full SPHD calculator →

Portfolio growth — MNMD vs SPHD

📍 MNMD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMNMDSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MNMD + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MNMD pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MNMD
Annual income on $10K today (after 15% tax)
$899.00/yr
After 10yr DRIP, annual income (after tax)
$1,745.09/yr
SPHD
Annual income on $10K today (after 15% tax)
$367.92/yr
After 10yr DRIP, annual income (after tax)
$485.62/yr
At 15% tax rate, MNMD beats the other by $1,259.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MNMD + SPHD for your $10,000?

MNMD: 50%SPHD: 50%
100% SPHD50/50100% MNMD
Portfolio after 10yr
$33.4K
Annual income
$1,312.18/yr
Blended yield
3.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MNMD right now

MNMD
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$28.00
+48.1% upside vs current
Range: $28.00 — $28.00
Altman Z
5.2
Piotroski
2/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MNMD buys
0
SPHD buys
0
No recent congressional trades found for MNMD or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMNMDSPHD
Forward yield10.58%4.33%
Annual dividend / share$2.00$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$40.2K$26.5K
Annual income after 10y$2,053.05$571.32
Total dividends collected$15.5K$5.1K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MNMD vs SPHD ($10,000, DRIP)

YearMNMD PortfolioMNMD Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$11,758$1,057.64$11,133$432.85+$625.00MNMD
2$13,743$1,162.18$12,363$450.36+$1.4KMNMD
3$15,974$1,269.54$13,695$467.39+$2.3KMNMD
4$18,472$1,379.15$15,138$483.90+$3.3KMNMD
5$21,255$1,490.43$16,697$499.88+$4.6KMNMD
6$24,346$1,602.82$18,382$515.31+$6.0KMNMD
7$27,766$1,715.78$20,198$530.17+$7.6KMNMD
8$31,538$1,828.79$22,157$544.46+$9.4KMNMD
9$35,687$1,941.36$24,266$558.18+$11.4KMNMD
10$40,239$2,053.05$26,536$571.32+$13.7KMNMD

MNMD vs SPHD: Complete Analysis 2026

MNMDStock

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.

Full MNMD Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this MNMD vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MNMD vs SCHDMNMD vs JEPIMNMD vs OMNMD vs KOMNMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.